Vilin Bio Med

26.20
-1.40
(-5.07%)
Market Cap
36.55 Cr
EPS
0.12
PE Ratio
230.00
Dividend Yield
0.00 %
Industry
0.00
52 Week High
29.30
52 Week Low
15.40
PB Ratio
1.69
Debt to Equity
0.35
Sector
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
30.89 %
Net Income Growth
-83.33 %
Cash Flow Change
-219.28 %
ROE
-93.91 %
ROCE
-79.90 %
EBITDA Margin (Avg.)
-66.43 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
TTM
Revenue
17
12
11
12
16
8
Expenses
16
11
10
10
15
7
EBITDA
1
1
1
3
1
2
Operating Profit %
5 %
7 %
7 %
21 %
5 %
8 %
Depreciation
0
0
0
0
0
0
Interest
0
0
1
1
1
0
Profit Before Tax
0
0
0
2
0
1
Tax
0
0
0
1
0
0
Net Profit
0
0
0
1
0
1
EPS in ₹
0.20
0.15
0.10
1.25
0.12
2.20

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
Total Assets
14
14
14
18
32
Fixed Assets
2
2
2
2
1
Current Assets
12
12
12
8
19
Capital Work in Progress
0
0
0
0
0
Investments
0
0
0
0
0
Other Assets
12
12
12
16
31
Total Liabilities
14
14
14
18
32
Current Liabilities
7
6
5
7
9
Non Current Liabilities
0
1
1
1
0
Total Equity
7
7
7
11
23
Reserve & Surplus
4
4
4
1
9
Share Capital
3
3
3
10
14

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
0
0
0
0
6
Investing Activities
0
0
0
0
0
Operating Activities
-2
-1
0
-2
-5
Financing Activities
2
1
-0
2
11

Share Holding

% Holding
Jun 2023
Sept 2023
Mar 2024
Sept 2024
Promoter
90.45 %
64.52 %
64.52 %
64.09 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.45 %
32.80 %
33.84 %
34.47 %
Others
0.10 %
2.68 %
1.65 %
1.45 %
No of Share Holders
827
659
585
581

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Technical Indicators

RSI(14)
Neutral
72.67
ATR(14)
Volatile
1.96
STOCH(9,6)
Neutral
57.91
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
0.89
ADX(14)
Weak Trend
18.55
UO(9)
Bearish
68.82
ROC(12)
Uptrend And Accelerating
39.75
WillR(14)
Overbought
-13.28